Overview

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical study is to assess the safety of multiple intracameral injections of EO2002 with and without topical Ripasudil.
Phase:
Phase 1
Details
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Collaborator:
Emmecell